SARS-CoV-2 spike T cell responses from vaccines or infection remain robust against Omicron

By | January 4, 2022
In a new study, a team of researchers from multi-national institutions discovered that 70-80% of CD4 and CD8 T cell responses to spike were consistent across research groups. Moreover, although having far more mutations, the magnitude of Omicron cross-reactive T cells was comparable to that of the Beta and Delta variants.